Bio-Inspired Albumin Platform for Synergistic Co-Delivery of Tanespimycin, Dasatinib, and Quercetin and Enhanced Therapeutic Efficacy in Triple-Negative Breast Cancer.
Despite increasing awareness of molecular subtypes of breast cancer, this heterogeneous malignant disease is still one of the leading causes of cancer death in women worldwide. Although receptor status may define the precise therapeutic targets, treatment of triple-negative breast cancer (TNBC) relies mainly on chemoth...